Literature DB >> 17372728

Localized muscle pain causes prolonged recovery after fatiguing isometric contractions.

Andrei Ciubotariu1, Lars Arendt-Nielsen, Thomas Graven-Nielsen.   

Abstract

The purpose of this study was to investigate the force and electromyographic (EMG) signal recorded from the muscles immediately after a sustained fatiguing contraction with or without muscle pain. Ten subjects performed sustained dorsi- and plantarflexions at two contraction levels (50 and 80% of maximum voluntary contraction) until exhaustion with or without muscle pain induced by injection of 6% hypertonic saline in one of the torque producing muscles. The muscle pain intensity was scored on a visual analogue scale (VAS, 0-10 cm). The root mean square (RMS) of the surface EMG signal from plantarflexors and dorsiflexors were estimated during maximum voluntary contractions (MVC) and ramp contractions before and after the fatiguing task at 0, 5, 10 and 15 min during the recovery phase. VAS scores immediately after the contractions with hypertonic saline (on average 3.2 +/- 1.1 cm) progressively decreased during recovery and no pain was experienced 15 min after the contraction. After the painful contraction the RMS-EMG during MVC was on average decreased (23.4 +/- 7.4%) compared to the non-painful condition both in muscles where pain was previously induced and in non-painful synergists. During recovery, the slope of the torque-EMG curve during ramp contraction was significantly decreased (28.4 +/- 8.1%) after the painful contraction compared to the control contraction both for the muscle previously exposed to pain and also the other active synergists. The decreased EMG during recovery after painful contractions compared with control was not accompanied by significant reductions in force during MVC indicating a change in the strategy for motor unit recruitment. This study shows that localized muscle pain inhibits muscle activation and increases the effects of fatigue on EMG recovery curves both for painful and non-painful synergists probably by a central effect. These effects can modify the normal patterns of synergistic activation and can also generate overload problems in muscle pain patients if compensatory motor control strategies are applied.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372728     DOI: 10.1007/s00221-007-0913-4

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   2.064


  39 in total

1.  Development of recommendations for SEMG sensors and sensor placement procedures.

Authors:  H J Hermens; B Freriks; C Disselhorst-Klug; G Rau
Journal:  J Electromyogr Kinesiol       Date:  2000-10       Impact factor: 2.368

2.  Effect of experimental muscle pain on motor unit firing rate and conduction velocity.

Authors:  Dario Farina; Lars Arendt-Nielsen; Roberto Merletti; Thomas Graven-Nielsen
Journal:  J Neurophysiol       Date:  2003-11-12       Impact factor: 2.714

3.  Depression of human electromyographic activity by fatigue of a synergistic muscle.

Authors:  P Sacco; R Newberry; L McFadden; T Brown; A J McComas
Journal:  Muscle Nerve       Date:  1997-06       Impact factor: 3.217

4.  Auditory EMG feedback during a sustained submaximum isometric contraction.

Authors:  A J Lloyd
Journal:  Res Q       Date:  1972-03

5.  Reflex origin for the slowing of motoneurone firing rates in fatigue of human voluntary contractions.

Authors:  B R Bigland-Ritchie; N J Dawson; R S Johansson; O C Lippold
Journal:  J Physiol       Date:  1986-10       Impact factor: 5.182

6.  Variability and interrelationships of surface EMG parameters during local muscle fatigue.

Authors:  W H Linssen; D F Stegeman; E M Joosten; M A van't Hof; R A Binkhorst; S L Notermans
Journal:  Muscle Nerve       Date:  1993-08       Impact factor: 3.217

7.  In vivo model of muscle pain: quantification of intramuscular chemical, electrical, and pressure changes associated with saline-induced muscle pain in humans.

Authors:  T Graven-Nielsen; A McArdle; J Phoenix; L Arendt-Nielsen; T S Jensen; M J Jackson; R H Edwards
Journal:  Pain       Date:  1997-01       Impact factor: 6.961

8.  Muscle fibre type populations of human leg muscles.

Authors:  V R Edgerton; J L Smith; D R Simpson
Journal:  Histochem J       Date:  1975-05

9.  Reflex inhibition of human soleus muscle during fatigue.

Authors:  S J Garland; A J McComas
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

10.  Lumbar muscle fatigue and chronic lower back pain.

Authors:  S H Roy; C J De Luca; D A Casavant
Journal:  Spine (Phila Pa 1976)       Date:  1989-09       Impact factor: 3.468

View more
  5 in total

Review 1.  Impact of clinical and experimental pain on muscle strength and activity.

Authors:  Thomas Graven-Nielsen; Lars Arendt-Nielsen
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

2.  Altered visual and feet proprioceptive feedbacks during quiet standing increase postural sway in patients with severe knee osteoarthritis.

Authors:  Rogerio Pessoto Hirata; Tanja Schjødt Jørgensen; Sara Rosager; Lars Arendt-Nielsen; Henning Bliddal; Marius Henriksen; Thomas Graven-Nielsen
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

3.  Fatigue and depression in sick-listed chronic low back pain patients.

Authors:  Hildegun Snekkevik; Hege R Eriksen; Tone Tangen; Trudie Chalder; Silje E Reme
Journal:  Pain Med       Date:  2014-04-09       Impact factor: 3.750

4.  Reduced Maximal Force during Acute Anterior Knee Pain Is Associated with Deficits in Voluntary Muscle Activation.

Authors:  Sauro Salomoni; Kylie Tucker; François Hug; Megan McPhee; Paul Hodges
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

5.  Do motor control genes contribute to interindividual variability in decreased movement in patients with pain?

Authors:  Bikash K Mishra; Tianxia Wu; Inna Belfer; Colin A Hodgkinson; Leonardo G Cohen; Carly Kiselycznyk; Albert Kingman; Robert B Keller; Qiaoping Yuan; David Goldman; Steven J Atlas; Mitchell B Max
Journal:  Mol Pain       Date:  2007-07-26       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.